About Correlia Biosystems
Correlia Biosystems is a company based in Berkeley (United States) founded in 2013. It operates as a HealthTech. Correlia Biosystems has raised $10.95 million across 7 funding rounds from investors including HHS, Neotribe and Cota Capital. Correlia Biosystems offers products and services including PIXI Benchtop Automated Immunoassays. Correlia Biosystems operates in a competitive market with competitors including Abingdon Health, Olink, Spear Bio, US BioTek Laboratories and Eclipse Bio, among others.
- Headquarter Berkeley, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Correlia Biosystems
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.95 M (USD)
in 7 rounds
-
Latest Funding Round
$1.25 M (USD), Series A
May 09, 2023
-
Investors
HHS
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Correlia Biosystems
Correlia Biosystems offers a comprehensive portfolio of products and services, including PIXI Benchtop Automated Immunoassays.
Automated protein quantification using microfluidic gel technology.
Funding Insights of Correlia Biosystems
Correlia Biosystems has successfully raised a total of $10.95M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $1.25 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Correlia Biosystems
Correlia Biosystems has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Neotribe and Cota Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Locked | Locked | Locked | |
|
Stage-agnostic venture capital investments are focused on US sectors.
|
Locked | Locked | Locked | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Correlia Biosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Correlia Biosystems
Investment portfolio details for Correlia Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Correlia Biosystems
Detailed financials for Correlia Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Correlia Biosystems Comparisons
Peer comparison for Correlia Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Correlia Biosystems
Correlia Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, Spear Bio, US BioTek Laboratories and Eclipse Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Provider of products and services for human protein biomarker research and development
|
|
| Locked | Locked | Locked |
Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers
|
|
| Locked | Locked | Locked |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| Locked | Locked | Locked |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| Locked | Locked | Locked |
An in vitro assay platform is provided for diagnostic solutions.
|
Detailed competitors of Correlia Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Correlia Biosystems
Complete news archive for Correlia Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Correlia Biosystems
Correlia Biosystems was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Correlia Biosystems is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Correlia Biosystems is a funded company, having raised a total of $10.95M across 7 funding rounds to date.
Correlia Biosystems is engaged in developing advanced protein quantification solutions through its PIXI platform, utilizing proprietary microfluidic gel technology. The company operates in the biotechnology sector, supporting applications in biopharmaceutical analysis, cell and gene therapy, and synthetic biology. Its solutions are designed for efficiency with ultra-low sample input, rapid turnaround, and high sensitivity, aiding scientific discovery in proteomics. Collaboration with top pharmaceutical companies is maintained to enhance assay development and laboratory integration.
Correlia Biosystems's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
Correlia Biosystems offers PIXI Benchtop Automated Immunoassays.
Correlia Biosystems has 4 investors. Key investors include HHS, Neotribe, Cota Capital, and Y Combinator.